Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Anne Vertigan, John Hunter Hospital, Australia

Assoc. Prof. Dr. Anne Vertigan is an experienced Speech Pathologist with a career spanning over 30 years. She holds multiple degrees, including a PhD in chronic cough and airway hyperresponsiveness. Dr. Vertigan is the Director of Speech Pathology at Greater Newcastle Acute Hospital and has extensive experience in leadership and clinical roles. She has contributed significantly to research, focusing on chronic cough, laryngeal dysfunction, and asthma. Dr. Vertigan has been invited to speak at numerous international conferences and has received several prestigious grants. She is also an Associate Editor for the European Respiratory Journal. ๐Ÿ“š๐ŸŽค๐Ÿ’ฌ๐Ÿ‘ฉโ€โš•๏ธ๐ŸŒ

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Anne Vertigan holds a B.App.Sc. (Speech Pathology) from La Trobe University (1991), an MBA from the University of Newcastle (2008), and a PhD from the University of Queensland, where she researched chronic cough and extrathoracic airway hyperresponsiveness syndrome, awarded in 2007. She also earned a Master in Clinical Epidemiology (2023) and a Master in Medical Statistics (2023) from the University of Newcastle. Dr. Vertigan’s academic and professional journey reflects her commitment to advancing knowledge in health, particularly in respiratory conditions and clinical research. ๐Ÿ“š๐ŸŽ“๐Ÿ’ก๐Ÿฉบ

Experience

Assoc. Prof. Dr. Anne Vertigan is a seasoned speech pathologist with an extensive career in healthcare leadership. She has served as the Director of Speech Pathology at the Greater Newcastle Acute Hospital Network since 2000. Previously, Dr. Vertigan was a Post-Doctoral Research Fellow at the NHMRC Centre for Clinical Excellence in Respiratory & Sleep Medicine (2008-2009). Her roles include District Profession Director of Speech Pathology at Hunter New England Health (2008-2015) and Director at John Hunter Hospital (1994-2000). With additional experience in various hospitals and community health centers, Dr. Vertigan has made significant contributions to speech pathology and healthcare. ๐Ÿฅ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ“š

Presentations

Assoc. Prof. Dr. Anne Vertigan is a renowned expert in laryngeal dysfunction, chronic cough, and voice disorders, delivering numerous invited talks at prestigious international conferences. In June 2024, she spoke at the Inducible Laryngeal Obstruction Conference in Pittsburgh, USA, on topics such as the hypersensitive larynx, laryngeal dysfunction, and the relationship between inducible laryngeal obstruction (ILO) and severe asthma. She also addressed dysphagia management and laryngeal hyperresponsiveness at the Phonosurgery Association of India in February 2024. Additionally, Dr. Vertigan shared her expertise at the French Society of ENT Congress and the ENT Head & Neck Instructional Course in Singapore. ๐ŸŒ๐ŸŽค๐Ÿ‘ฉโ€โš•๏ธ

Grants

Assoc. Prof. Dr. Anne Vertigan has been awarded several prestigious grants and recognitions for her research in respiratory health. These include the $10,000 Ignite EMCR Equipment Grant (2018) for BioRadio Respiratory Inductive Plethysmography, and the $5,000 Strategic Research Pilot Grant (2020) to understand breathlessness in asthma. She also contributed to the $320,490.62 Medical Research Futures Fund on bushfire impact (2020), and the NHMRC’s $2.5 million CREATT Centre for asthma research (2020). In 2021, her work on non-pharmacological treatments for interstitial lung diseases won the SPP Robalo Cordeiro Award. Her latest project focuses on minimizing corticosteroid use in asthma. ๐Ÿซ๐Ÿ’ก๐ŸŒฟ

Research Focus

Assoc. Prof. Dr. Anne Vertigan’s research primarily focuses on respiratory diseases, particularly chronic cough, breathlessness, and asthma. She investigates the psychophysiological correlates of breathlessness and the impact of exposure to environmental factors like wildfire smoke. Dr. Vertigan also explores respiratory issues related to vocal cord dysfunction and laryngeal hypersensitivity. She is involved in studies aimed at improving diagnostic and therapeutic approaches for conditions such as chronic cough in children and adults. Her work aims to enhance understanding and management of airway conditions in clinical settings. ๐ŸŒฌ๏ธ๐Ÿซ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ”ฌ๐ŸŒฑ

Publication top Notes

Abnormal breathing pattern features in chronic refractory cough

Understanding Breathlessness Burden and Psychophysiological Correlates in Asthma

Respiratory Diseases Associated With Wildfire Exposure in Outdoor Workers

Misconceptions on behavioral cough suppression therapy for pediatric nonspecific cough: A response to Weinberger and Buettner’s commentary on Fujiki et al.

Living With Asthma and Vocal Cord Dysfunction/Inducible Laryngeal Obstruction: โ€œI Just Can’t Get Air Inโ€

Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia

Susan Gonya | Medicine and Health Sciences | Best Researcher Award

Susan Gonya | Medicine and Health Sciences | Best Researcher Award

Ms Susan Gonya, University of New Hampshire, United States

Based on Ms. Susan Gonya’s background, she seems to be a strong candidate for the Best Researcher Award due to her extensive research, diverse professional experience, and significant contributions to public health and safety. Hereโ€™s a breakdown of her qualifications:

Publication profile

Scopus

Education ๐Ÿ“š

Ms. Susan Gonya holds multiple degrees with top grades, including a Master of Science in Evidence-Based Practice from the University of New Hampshire and a Master of Arts in Nutrition Education and Clinical Nutrition from Immaculata University. Her academic background underscores a deep commitment to learning and research excellence.

Research Interests and Contributions ๐Ÿ”ฌ

Her research focuses on dietary mold contaminants and their effects on infants and children. She investigates mycotoxins in the food supply and their impact on human health, aiming to develop mitigation strategies. Her work addresses critical issues in public health and safety and is poised for significant impact, as evidenced by her upcoming manuscript on dietary mycotoxin levels.

Professional Experience ๐Ÿฅ

With over two decades in healthcare, Ms. Gonya has worked as a Critical Care Nurse and Research Dietitian, leading projects on dietary contaminants and improving enteral nutrition interventions. Her roles demonstrate her practical application of research findings and her commitment to improving patient care.

Honors and Awards ๐Ÿ†

Ms. Gonya has received numerous awards, including the “Students Choice Award” and the “Nursing Excellence Award,” recognizing her research and professional excellence. Her accolades from conferences and organizations highlight her impact and dedication to her field.

Certifications and Memberships ๐Ÿ…

Her certifications in critical care, quality and safety, and nutrition counseling, along with memberships in several professional associations, reflect her ongoing commitment to professional development and collaboration.

Personal Interests ๐ŸŒฟ

Ms. Gonyaโ€™s interests in organic farming, recipe development, and fitness align with her professional focus on nutrition and health. These activities complement her research and contribute to her holistic approach to wellness.

Publication top notes

Are Infants and Children at Risk of Adverse Health Effects from Dietary Deoxynivalenol Exposure? An Integrative Review

Do we really know how much we are feeding our patients?

 

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Prof Dr Gulali Aktas, Abant Izzet Baysal University Hospital, Turkey

Prof. Dr. Gulali Aktas is a dedicated physician with 24 years of experience in internal medicine. As an academician for 13 years, he has mentored countless medical students and contributed to significant research. He holds an MD and Associate Professorship from Abant Izzet Baysal University. His prolific work includes 183 international journal publications, 19 conference presentations, and 11 book chapters. Recognized for his excellence, he was nominated for the Raise the Line Faculty Award in 2022 and is listed in Stanford University’s top 2% scientists. Fluent in Turkish, English, and basic German, he champions patient-centered care and lifelong learning. ๐Ÿฅ๐Ÿ“š๐ŸŒŸ

Publication profile

google scholar

Education

Dr. Gulali Aktas is an Associate Professor of Internal Medicine since 2015. They completed their Internal Medicine residency (PhD equivalent) at Ondokuz Mayis University, Samsun, Turkey (2003-2008), and Pulmonology residency at Yedikule Training and Research Hospital, Istanbul, Turkey (2002-2003). They earned their MD from Ondokuz Mayis University in 2000. With 211 research contributions published in peer-reviewed journals and an impressive H-index of 35 (WoS), 42 (Google Scholar), and 36 (Scopus), Dr. Gulali Aktas is a prominent researcher. Fluent in Turkish, English, and basic German, they are known for their honesty, hard work, optimism, and foresight. ๐ŸŒŸ๐Ÿ“š๐Ÿฉบ๐ŸŒ

Experience

From 2011 to 2014, courses such as Dyspnea and Edema, Approach to Chest Pain, Fever and Hyperthermia, and Leukopenia and Leukocytosis were taught in the spring, while Chronic Leukemia, Aplastic Anemia and Myelodysplasia, and Principles of Blood Transfusion were covered in the autumn. Rheumatology topics like Anamnesis, Physical Examination, and Laboratory Test Analysis were emphasized. Other subjects included Familial Mediterranean Fever, Behcetโ€™s Disease, Chronic Pancreatitis, Liver Cirrhosis, Esophageal Diseases, Colon Polyps, Celiac Disease, Chronic Viral and Non-Viral Hepatitis, and Mesenteric Ischemia. ๐Ÿฉบ๐Ÿ“šโœจ

Presentations

Dr. Gulali AktaลŸ has presented several notable studies. At the 30th World Congress of Endourology in 2012, his team discussed “Warfarin intoxication induced bilateral renal hematoma” (๐Ÿ“š๐Ÿฉธ). He compared surgical techniques for pylonidal sinus surgery and explored sleep quality in IBS patients at the XVI Annual European Society of Surgery (๐Ÿ”ช๐Ÿ’ค). In 2013, at the 50th ERA-EDTA Congress, he highlighted the effects of nocturnal blood pressure on hemodialysis patients’ nutrition (๐ŸŒ™๐Ÿฉบ). His research on metabolic syndrome, presented at the 10th Metabolic Syndrome Symposium, investigated platelet volume, epicardial adipose tissue, and non-alcoholic hepatosteatosis (๐Ÿฉธ๐Ÿ“ˆ). At the 51st ERA-EDTA Congress, he examined atrial conduction in hemodialysis patients (โค๏ธ๐Ÿฉบ).

Research focus

G Aktas focuses on the use of hematological and biochemical markers as diagnostic and prognostic tools in various medical conditions. His research includes studies on the neutrophil-to-lymphocyte ratio as an indicator for diabetic control in type 2 diabetes mellitus and Hashimoto’s thyroiditis. He also explores the predictive value of the uric acid to HDL cholesterol ratio for metabolic syndrome and diabetes control, as well as novel inflammatory markers derived from hemogram parameters in irritable bowel syndrome and COVID-19. His work aims to improve diagnostic accuracy and patient outcomes. ๐Ÿฉธ๐Ÿ”ฌ๐Ÿ“Š

Publication top notes

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis

Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus

Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus

Diabetes control could through platelet-to-lymphocyte ratio in hemograms

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Could red cell distribution width be a marker in Hashimotoโ€™s thyroiditis?

Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men

Hematological predictors of novel Coronavirus infection